Chimeric antigen receptor (CAR) T-cell therapy has shown significant promise in fighting blood cancers. Some studies indicate 9 of 10 people with acute lymphoblastic leukemia treated with CAR-T therapy experienced full remission. Since 2017, the FDA has approved 6 CAR-T therapies to treat blood cancers, including lymphomas, leukemia, and multiple
Unlike other industries, biotech companies require multiple funding cycles to fuel meticulously planned clinical trials that take more than a decade to complete. Biotech companies can’t pause development or quickly pivot to a more profitable product during difficult times. The necessity to continue clinical development of their therapeutics is why
For first-time CEOs who’ve recently made the transition from academia to entrepreneurship, building a successful biotech startup goes well beyond realizing their first rounds of funding.
A groundbreaking discovery, shifting milestones, and a rebrand made the Opna Bio project an exciting and dynamic endeavor for everyone involved. Opna Bio is a clinical stage company focused on the discovery and development of innovative oncology therapeutics. It was formed around the groundbreaking new discovery of a novel oncology
There is no surprise that life sciences field is very competitive, some areas more than others. It is a great challenge for up and coming life science companies to differentiate themselves among established competition, and – more importantly – communicate competitive advantages to investors. Naturally, scientists turn to data comparison
Growing life sciences companies require significant investment to stay afloat. And oftentimes the confidence in the company’s potential depends on how clear and compelling the pitch deck is. When Theoria Creative develops a scientific presentation deck for clients, we give careful consideration to each slide; every word, graphic and high-level message must be clearly
Biotech and pharmaceutical companies have a unique growth trajectory compared to other industries. They require a lot of capital and years of trial-and-error to get their drug product to market. Those companies choosing to raise public capital encounter an additional challenge: frequent investor presentations at roadshows and investment conferences to
When presenting at high-stakes meetings — whether you are pitching to investors, soliciting partnerships or justifying value proposition at a healthcare conference — having an effective corporate presentation is imperative for a successful outcome. It’s no secret that our attention spans have become increasingly hard to capture. More than ever
Theoria Creative is a marketing firm, enabling life sciences companies to clearly communicate complex science to investors, partners, and peers. We develop communication strategy, messaging, positioning, and prepare a set of illustrated materials that help companies clearly and succinctly articulate their value at high stakes meetings.
We share useful tips and company news in a monthly newsletter.
